Shulin Li
Impact in
- Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 1%
Papers in
- Oncology 65
- CAR-T cell therapy research 20
- Cancer Cells and Metastasis 18
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Arun Satelli (15 shared papers)Abhisek Mitra (18 shared papers)Miles Wilkinson (9 shared papers)Lopa Mishra (15 shared papers)Xueqing Xia (54 shared papers)Jun Yan (16 shared papers)Jiemiao Hu (27 shared papers)Amy B. Heimberger (14 shared papers)
- Journals
- Cancer Research (14 papers)Clinical Cancer Research (7 papers)The Journal of Immunology (5 papers)Molecular Therapy (5 papers)Cancer Letters (5 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Shulin Li
202 papers receiving 8.7k citations
Shulin Li's Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 2.5k
- Cancer Research 1.2k
- Immunology 1.8k
- Genetics 562
- Molecular Biology 3.5k
Countries citing papers authored by Shulin Li
This map shows the geographic impact of Shulin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shulin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shulin Li more than expected).
Fields of papers citing papers by Shulin Li
This network shows the impact of papers produced by Shulin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shulin Li. The network helps show where Shulin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Shulin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vimentin in cancer and its potential as a molecular target for cancer therapy Hit paper breakdown → | 2011 | 1230 |
| 2 | The Role of the Liver in Sepsis Hit paper breakdown → | 2014 | 408 |
| 3 | EMT, CTCs and CSCs in tumor relapse and drug-resistance Hit paper breakdown → | 2015 | 397 |
| 4 | 2017 | 311 | |
| 5 | Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target Hit paper breakdown → | 2018 | 299 |
| 6 | 1995 | 267 | |
| 7 | 2013 | 263 | |
| 8 | 2014 | 194 | |
| 9 | 1998 | 173 | |
| 10 | 2016 | 157 | |
| 11 | 2014 | 154 | |
| 12 | 2013 | 146 | |
| 13 | 2014 | 135 | |
| 14 | 2020 | 127 | |
| 15 | 2012 | 119 | |
| 16 | 2017 | 116 | |
| 17 | 2001 | 108 | |
| 18 | 2020 | 102 | |
| 19 | 2020 | 96 | |
| 20 | 1996 | 93 |
About Shulin Li
Shulin Li is a scholar working on Oncology, Molecular Biology, Immunology, Biotechnology and Genetics, having authored 208 papers that have together received 8.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Microbial Inactivation Methods (19 papers), Cancer Cells and Metastasis (18 papers), Immune Cell Function and Interaction (18 papers), Virus-based gene therapy research (16 papers), Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Immune cells in cancer (9 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.2k citations), Immunology (1.8k citations), Genetics (562 citations) and Molecular Biology (3.5k citations). Shulin Li has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Arun Satelli, Abhisek Mitra, Miles Wilkinson, Lopa Mishra, Xueqing Xia, Jun Yan, Jiemiao Hu, Amy B. Heimberger, Qing H. Meng and Zachary Brownlee. Their work appears in journals such as Cancer Research, Clinical Cancer Research, The Journal of Immunology, Molecular Therapy and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.